6ix — Find Your Next Investment

Discover investor relations events, company profiles, and investment opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Latest Press Releases

Time	Headline
51m ago	e.l.f. Cosmetics Fuels Katherine Legge's Return to the Indianapolis 500 with eyes.lips.fuel. Takeover
1h ago	Investor Update Webcast March 2026 Quarter
1h ago	Citi Singapore receives dual award recognition from FinanceAsia and Forbes
3h ago	Eyebright Medical Releases Its 2025 Annual Report and Sustainability Report
3h ago	The Trade Desk Powers Open Internet Growth with DramaBox Short Drama Partnership

About

Sangamo Therapeutics Inc (NASDAQ:SGMO) — investor relations, events, news, and company updates on 6ix.

Latest News

Sangamo Therapeutics Reports Recent Business Highlights And Fourth Quarter And Full Year 2025 Financial Results

Sangamo Therapeutics Announces Fourth Quarter and Full Year 2025 Earnings Call

Sangamo Therapeutics Advances Rolling Submission of BLA to U.S. FDA for ST-920 in Fabry Disease

Sangamo Therapeutics Presents Detailed Data from Registrational STAAR Study in Fabry Disease at WORLDSymposium™ 2026

Sangamo Therapeutics Announces Pricing of $25.0 Million Underwritten Offering

Financials

Revenue

$39.55 M

Market Cap

$124.32 M

EPS

-0.44

Community Chat

Ask AI